Pioneering Medicines
Biotechnology Research • 
Cambridge, Massachusetts, United States • 101-200 Employees
Company overview
| Headquarters | 55 Cambridge Parkway, Suite 800E, Cambridge, MA 02142, US |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 101-200 |
| Socials |
Key Contacts at Pioneering Medicines
Tara Depeau
Director Talent Acquisition
Shravan Sukumar
Director Ai/Ml And Data Science
Robert Citorik
Senior Director, Product Innovation
Min Wan
Senior Director, Metabolic Disease
Stephen Gleason
Senior Director, Clinical Development Operations Lead
Heidi Kocalis
Director, In Vivo Pharmacology
Chenying Guo
Senior Director, Translational Sciences
Erik Wilker
Head Of Pharmacology, Executive Director
Namita Dodwadkar
Director, Drug Delivery
Lana Dinić
Executive Director, Portfolio Strategy And Operations
Pioneering Medicines Email Formats
Pioneering Medicines uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@flagshippioneering.com), used 54% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@flagshippioneering.com | 54% |
{first initial}{last name} | jdoe@flagshippioneering.com | 39.1% |
{last name}{last name} | doedoe@flagshippioneering.com | 5.7% |
{last name}{first initial} | doej@flagshippioneering.com | 1.1% |
About Pioneering Medicines
Pioneering Medicines, Flagship Pioneering’s in house drug discovery and development unit, is dedicated to conceiving and developing a broad portfolio of life-changing treatments for patients built from Flagship’s innovative platforms. Harnessing the drug development expertise of its team together with the power of Flagship’s multiple scientific platforms, Pioneering Medicines explores and identifies new product concepts and then works jointly with Flagship’s companies to form integrated teams that advance medicines through robust discovery and early clinical development. Pioneering Medicines also partners with external collaborators across biopharma throughout the R&D process, applying its unique approach to the R&D priorities of partners through highly co-creative relationships. The team leads Flagship’s Innovation Supply Chain Partnerships with Novo Nordisk and Pfizer to speed innovation in drug development and bring novel therapies to patients, as well as a partnership with the Cystic Fibrosis Foundation to develop therapeutics that address the unmet needs of people living with cystic fibrosis.
Pioneering Medicines revenue & valuation
| Annual revenue | $10,300,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $32,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Pioneering Medicines has 38 employees across 9 departments.
Departments
Number of employees
Funding Data
Pioneering Medicines has never raised funding before.
France
Canada
United Kingdom
Frequently asked questions
4.8
40,000 users
